SEC Form 4 · accession 0001209191-18-032964
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy J. Arens
Officer — Interim VP, Finance, and CFO
Period of report
May 22, 2018
Accepted (ET)
May 24, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 22, 2018 | S | 7,000 | $49.2008 | D | 32,430 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the weighted average price of 7,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 22, 2018 with sale prices ranging from $48.85 to $49.325 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.